Playing back the response to your US listing question @arnies, I think they're looking at it pretty seriously?
Choice lines in Jon's response:
"we're actively considering it at the moment"...
"absolutely, it's something we're considering"...
"there's a lot of interest in the US in us"...
"absolutely it's on our radar screen".
That said, I was 100% wrong about them "engaging third parties" re US listing. I must have confused them "being helped by intermediaries" (re getting to the right people at big bio funds). I'll blame the kids rather than my inattentiveness there (sorry!) haha
Keen to know if anyone else re-listened and has opinions either way? I might just be hearing what I want to hear, but in response to the "big bio funds" question, he did emphasise a few times that there was a lot of interest from US/Europe and suggest that the ASX might be what's getting in the way there...?
See how we go. It's a shame the market doesn't seem to care, but I thought it was a cracker of a Q&A!
Cheers.
Ann: Neuren corporate presentation, 24 February 2021, page-20
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.71 |
Change
-0.590(3.41%) |
Mkt cap ! $2.135B | |||
| Open | High | Low | Value | Volume |
| $17.50 | $17.55 | $16.57 | $10.01M | 594.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 598 | $16.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.87 | 1676 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |